Non classé
Empowering Cancer Patients: SmartCARE Showcase Event
The SmartCARE Showcase Event, organised by the European Cancer Organisation, brought together patient advocates, clinicians, and IT experts to intr...
Advancing Rare Cancer Care: DiCE at the EURACAN Board Meeting
On the 7th and the 8th of November, Laura Urena from Digestive Cancers Europe (DiCE) and a member of EURACAN Patient Advocacy Group (EPAG), partici...
United Against Cancer: Driving Policy and Advocacy at the European Cancer Summit 2024
This event explored innovative strategies to address inequalities and advance cancer care across Europe, aligning closely with Digestive Cancers Eu...
Tevimbra (tislelizumab) Receives New European Recommendations for Oesophageal and Gastric Cancer
Tevimbra (tislelizumab) receives CHMP recommendations for treating PD-L1-positive oesophageal squamous cell carcinoma and gastric/gastroesophageal ...
Ponsegromab: A New Hope for Cancer Cachexia Treatment
Cancer cachexia, a severe wasting syndrome often experienced by patients with advanced cancer, leads to substantial weight loss, muscle wasting, an...
Empowering Patient Voices at the National Congress of Medical Oncology
I am thrilled to share my experience of being invited to speak at the National Congress of Medical Oncology opening ceremony. This prestigious even...
Zorana Maravic, DiCE CEO, Co-Chairs Global Effort for Medicine Accessibility
In an inspiring move toward global healthcare improvement, Zorana Maravic, CEO of Digestive Cancers Europe (DiCE), took centre stage as co-chair of...
New Era in Gastric Cancer Treatment: Zolbetuximab Gains EU Approval
On September 20th, 2024, the European Commission approved zolbetuximab with chemotherapy for advanced Gastric and GastroEsophageal Junction cancers...
Hepatocellular Carcinoma Prevention & Diagnosis: DiCE Publishes Project Results
DiCE’s mapping research project on HCC prevention and diagnosis in Europe reveals rising incidence and mortality rates. The results, published du...
DiCE Attends the TOGAS EU Project Consortium Meeting and Conference
Zorana Maravic, our CEO, and Ana Martins participated in the TOGAS Consortium Meeting and TOGAS Conference on 11-12 September at Fundação Eng. An...
